Clinical trial
Role of RhuMab-E25 in Reducing Exhaled NO in Allergic Asthma
NCT00829179 is registered in ClinicalTrials.gov with Duke University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Role of RhuMab-E25 in Reducing Exhaled NO in Allergic Asthma
- Lead sponsor
- Duke University
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 31, 2002
- Completion date
- July 31, 2004
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
allergic asthma